These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 247708)

  • 1. [Drug committee: committee is going to bring about a more knowledgeable attitude to the selection of drugs].
    Hagelsten JO
    Sygeplejersken; 1978 Mar; 78(12):4-7, 20. PubMed ID: 247708
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug committees: committees which will bring about a more conscious attitude to the choice of drugs].
    Hagelsten JO
    Sygeplejersken; 1978 Mar; 78(12):4-7, 20. PubMed ID: 254427
    [No Abstract]   [Full Text] [Related]  

  • 3. Developing Drug Reports for the Pharmacy and Therapeutics Committee.
    Longe RL; Riley MW
    Am J Hosp Pharm; 1976 Jul; 33(7):651-2. PubMed ID: 941920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The goals and functions of a P & T committee.
    Sudds TW; Williams RR
    Hosp Formul; 1985 Nov; 20(11):1163-5, 1171, 1174. PubMed ID: 10274572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Criteria for choice of preparations in a drug committee].
    Lunde PK
    Tidsskr Nor Laegeforen; 1975 Jan; 95(1):37-40. PubMed ID: 1111161
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug committees towards the regions. The Danish Society of Clinical Pharmacology].
    Reuther LØ; Brock B;
    Ugeskr Laeger; 2007 Mar; 169(12):1113. PubMed ID: 17394824
    [No Abstract]   [Full Text] [Related]  

  • 7. [Medical experts groups and choice of medications. A fair prioritization process guarantees the reliability of the choice of medications].
    Garpenby P
    Lakartidningen; 2004 Aug; 101(32-33):2480-2, 2484. PubMed ID: 15346621
    [No Abstract]   [Full Text] [Related]  

  • 8. Developing policy for handling investigational drugs.
    Ebel JA
    Hosp Manage; 1967 Aug; 104(2):58-64. PubMed ID: 6073958
    [No Abstract]   [Full Text] [Related]  

  • 9. Improving pharmacy and therapeutics committee operations.
    Cohen MR; Klapp D; Miller KB; Shaffer VL; Slotfeldt M; Miller DE
    Am J Hosp Pharm; 1984 Sep; 41(9):1767-77. PubMed ID: 6496511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug and therapeutics committees in Danish hospitals: a survey of organization, activities and drug selection procedures.
    Plet HT; Hallas J; Nielsen GS; Kjeldsen LJ
    Basic Clin Pharmacol Toxicol; 2013 Apr; 112(4):264-9. PubMed ID: 23107106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing a pharmaceutical purchasing strategy.
    Hynniman CE
    Hosp Formul; 1992 Sep; 27(9):918-20, 925-7. PubMed ID: 10171225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacy.
    Jeffrey LP
    Hospitals; 1972 Apr; 46(7):155-60. PubMed ID: 4552323
    [No Abstract]   [Full Text] [Related]  

  • 13. American Society of Hospital Pharmacists. Product selection survey.
    Am J Hosp Pharm; 1972 Jun; 29(6):506. PubMed ID: 5035970
    [No Abstract]   [Full Text] [Related]  

  • 14. Mission, role, and functions of the P & T Committee.
    Bell JE; Evans PJ; Standish RC
    Hosp Formul; 1983 Jun; 18(6):639-40, 643-6. PubMed ID: 10260202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age: a growing P & T concern.
    Lipman AG
    Hosp Formul; 1983 May; 18(5):475. PubMed ID: 10260197
    [No Abstract]   [Full Text] [Related]  

  • 16. P & T Committee rises to challenges of the changing healthcare environment.
    Eybel CE; Pierpaoli PG; Carasiti ME
    Hosp Formul; 1991 Nov; 26(11):886-8, 890-4. PubMed ID: 10114819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P & T Committee role in advocating rational therapeutics.
    Borreson R
    Hosp Formul; 1986 May; 21(5):590-8. PubMed ID: 10311625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overdosage and-or poisoning--the information gap.
    Ellenhorn MJ
    J Clin Pharmacol; 1973; 13(5):181-9. PubMed ID: 4488653
    [No Abstract]   [Full Text] [Related]  

  • 19. How a longstanding P & T Committee identifies and meets current therapeutic challenges.
    Stross J; de Leon R; Volger B
    Hosp Formul; 1991 Sep; 26(9):717-22, 724. PubMed ID: 10114003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Are the recommendations of the drug committee followed? A comparison of the prescribing pattern of anti-angina drugs in general practice and hospitals in relation to the recommendations].
    Salomonsen H; Beierholm V
    Ugeskr Laeger; 1991 Aug; 153(34):2333-5. PubMed ID: 1897041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.